Association between statin use and sex hormone in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort.
暂无分享,去创建一个
R. Kronmal | A. Folsom | D. Duprez | A. Dobs | P. Ouyang | D. Vaidya | S. Konety | H. Yarmohammadi | O. Oluleye | Dhananjay Vaidya | Suma H Konety
[1] Daniel E Forman,et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.
[2] F. Jing,et al. The Effect of Statins on Levels of Dehydroepiandrosterone (DHEA) in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis , 2019, Medical science monitor : international medical journal of experimental and clinical research.
[3] D. Waters,et al. Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. , 2015, Journal of the American College of Cardiology.
[4] G. Howard,et al. Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation. , 2014, Circulation.
[5] Nancy R Cook,et al. Statins: new American guidelines for prevention of cardiovascular disease , 2013, The Lancet.
[6] Jeanne Lenzer. Majority of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers , 2013, BMJ.
[7] C. Sibley,et al. Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosis , 2013, BMC Medical Research Methodology.
[8] Judith S. Hochman,et al. Reprint: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. , 2013, Journal of the American Pharmacists Association : JAPhA.
[9] N. Rifai,et al. Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III , 2010, Cancer Causes & Control.
[10] Yasuo Ohashi,et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2010, The Lancet.
[11] M. Jarvelin,et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes , 2009, Human molecular genetics.
[12] David J Hunter,et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. , 2009, The New England journal of medicine.
[13] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[14] T. Travison,et al. Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey , 2007, Cancer Epidemiology Biomarkers & Prevention.
[15] M. Szklo,et al. Endogenous sex hormones and glucose tolerance status in postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.
[16] H. Aldred,et al. Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes , 2007, Diabetes Care.
[17] E. Ding,et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.
[18] Prof. Dr. med. M. Böhm,et al. Does statin therapy influence steroid hormone synthesis? , 2004, Zeitschrift für Kardiologie.
[19] S. Reis,et al. Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE). , 2002, The American journal of medicine.
[20] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[21] T. Ushiroyama,et al. Beneficial effects of pravastatin in peri- and postmenopausal hyperlipidemic women: a 5-year study on serum lipid and sex hormone levels. , 2001, Maturitas.
[22] A. Dobs,et al. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. , 2000, Metabolism: clinical and experimental.
[23] A. Dobs,et al. Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients. , 2000, Metabolism: clinical and experimental.
[24] A. Vermeulen,et al. A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.
[25] M. Zini,et al. Testicular function in hypercholesterolemic male patients during prolonged simvastatin treatment. , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[26] A. Dobs,et al. Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. , 1993, Metabolism: clinical and experimental.
[27] V. Brown. [The National Cholesterol Education Program]. , 1990, Arzneimittel-Forschung.
[28] G. Guarini,et al. Plasma Cortisol and Testosterone in Hypercholesterolaemia Treated with Clofibrate and Lovastatin , 1989, The Journal of international medical research.
[29] H. Brewer,et al. Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin. , 1987, Journal of Clinical Endocrinology and Metabolism.
[30] N. Orentreich,et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. , 1984, The Journal of clinical endocrinology and metabolism.